Matt Rael

Matt Rael is an experienced regulatory affairs professional with a robust background in the biotechnology and pharmaceutical industries. Currently serving as Senior Director of Regulatory Affairs at Aspen Neuroscience, Inc. since April 2022, Matt has previously held significant roles at Ionis Pharmaceuticals, Inc., including Director and Associate Director of Regulatory Affairs from April 2017 to April 2022. Earlier experience includes positions at Sarepta Therapeutics, where Matt advanced from Regulatory Affairs Specialist to Senior Manager. Matt holds a Master of Science in Biomedical Regulatory Affairs and a Bachelor of Arts in Anthropology, both from the University of Washington.